SNORD114-2: A Potential Drug Target and Biomarker (G767578)

Target Name: SNORD114-2

NCBI ID: G767578

SNORD114-2

Other Name(s): Small nucleolar RNA, C/D box 114-2 | 14q(II-2) | small nucleolar RNA, C/D box 114-2

SNORD114-2: A Potential Drug Target and Biomarker

Small nucleolar RNA (snRNA), also known as microRNA (miRNA), is a non-coding RNA molecule that plays a crucial role in various cellular processes. One of the well-known types of snRNA is C/D box 114-2 ( SNORD114-2), which is expressed in different cell types and has been shown to have various functions, including regulating gene expression, DNA replication, and chromatin remodeling.

Recent studies have identified SNORD114-2 as a potential drug target and biomarker, which could be useful for the development of new therapeutic approaches for various diseases. In this article, we will explore the biology of SNORD114-2 and its potential as a drug target and biomarker.

The Biology of SNORD114-2

SNORD114-2 is a 24.8-nt RNA molecule that is found in various cell types, including muscle, liver, and brain cells. It is expressed in different levels in different cell types and has been shown to play a role in regulating gene expression and various cellular processes.

One of the well-known functions of SNORD114-2 is its role in regulating gene expression. Studies have shown that SNORD114-2 can interact with various protein factors, including histone modifications, non-histone modifications, and RNA-binding protein (RBP) proteins . These interactions can alter the stability and translation efficiency of target genes, which can lead to the regulation of cellular processes such as cell growth, apoptosis, and inflammation.

Another function of SNORD114-2 is its role in DNA replication. Studies have shown that SNORD114-2 can interact with the protein DNMTase II, which is involved in DNA replication and repair. These interactions can alter the efficiency of DNA replication and contribute to the regulation of gene expression.

In addition to its role in regulating gene expression and DNA replication, SNORD114-2 has also been shown to play a role in chromatin remodeling. Chromatin remodeling is a process that involves the alteration of the structure and composition of chromatin, which can lead to the Regulation of gene expression. Studies have shown that SNORD114-2 can interact with the protein HFN1, which is involved in chromatin remodeling. These interactions can alter the stability and composition of chromatin and contribute to the regulation of gene expression.

Potential drug targets and biomarkers

The potential drug targets for SNORD114-2 are vast, as it has been shown to play a role in various cellular processes that are important for human health and disease. One of the potential drug targets for SNORD114-2 is its role in regulating gene expression , which can be targeted by small molecules that can inhibit the activity of SNORD114-2. For example, inhibitors of the RNA binding activity of SNORD114-2, such as small molecules that bind to the N-terminal region of the protein, could be useful for the inhibition of gene expression.

Another potential drug target for SNORD114-2 is its role in DNA replication, which can be targeted by small molecules that can inhibit the activity of SNORD114-2. For example, inhibitors of the DNA replication complex, which include small molecules that bind to the protein responsible for DNA replication, could be useful for the inhibition of DNA replication.

In addition to its potential drug targets, SNORD114-2 has also been shown to be a potential biomarker for various diseases. The expression of SNORD114-2 has been shown to be reduced in various diseases, including cancer, neurodegenerative diseases, and autoimmune diseases. These reduced levels of SNORD114-2 could be used as a biomarker for the diagnosis and monitoring of these diseases.

Conclusion

In conclusion, SNORD114-2 is a potential drug target and biomarker that has been shown to play a role in various cellular processes that are important for human health and disease. The regulation of gene expression, DNA replication, and chromatin remodeling by SNORD114-2 makes it an attractive target for small molecules that can inhibit its activity. Further research is needed to fully understand the biology of SNORD114-2 and its potential as a drug

Protein Name: Small Nucleolar RNA, C/D Box 114-2

The "SNORD114-2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNORD114-2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets